Study shows 2 drugs may help UC patients avoid colectomy | Combo treatments show high SVR rates in HCV genotype 1 | Study finds HCV genotype 1 is most common
Web Version
 
July 30, 2014
CONNECT WITH ACG®  FacebookTwitter
ACG SmartBrief
ACG SmartBrief is an official publication of the ACG.
FORWARD|ARCHIVE

Clinical Updates
Study shows 2 drugs may help UC patients avoid colectomy
Some ulcerative colitis patients may be able to avoid needing a colectomy by taking infliximab or cyclosporine A, researchers reported. The treatments both had short-term and long-term efficacy, the study found. Healio (free registration) (7/25)
Share: LinkedInTwitterFacebookGoogle+Email
Combo treatments show high SVR rates in HCV genotype 1
Daclatasvir plus asunaprevir and simeprevir with sofosbuvir are two promising combination treatments for hepatitis C genotype 1, researchers reported. The studies found sustained virological response rates of 90% or higher using the combinations. DoctorsLounge.com (7/28)
Share: LinkedInTwitterFacebookGoogle+Email
Study finds HCV genotype 1 is most common
A University of Oxford study found 46.2% of all hepatitis C cases worldwide are HCV genotype 1, making it the most common form. Genotypes 3, 2, 4 and 6 were the next most prevalent, and higher-income countries accounted for 66% of genotype 1 cases. Healio (free registration) (7/29)
Share: LinkedInTwitterFacebookGoogle+Email
More C. diff cases linked to community settings, study says
More Clostridium difficile infections are being acquired in community settings than in hospitals, Kaiser Permanente researchers reported. Electronic health records data on Kaiser patients in Southern California showed 49% of cases were linked to community settings or undetermined sources, and 31% were tied to previous hospital stays. Medscape (free registration)/Reuters (7/30)
Share: LinkedInTwitterFacebookGoogle+Email
 
Legal & Regulatory
U.S. Senate OKs McDonald as next VA secretary
Former Procter & Gamble CEO Robert McDonald was approved unanimously by the U.S. Senate as the new secretary of Veterans Affairs. McDonald is a West Point graduate and replaces Gen. Eric Shinseki, who resigned amid the controversy over VA health care backlogs. USA Today (7/29)
Share: LinkedInTwitterFacebookGoogle+Email
Medicare trust fund on pace to last until 2030, government says
Better economic conditions and payment cuts mandated by the Affordable Care Act slowed the depletion of the Medicare trust fund's assets last year, according to a government report. That means the trust fund won't be depleted until 2030, four years later than what was predicted in 2013, the report said. Bloomberg (7/28)
Share: LinkedInTwitterFacebookGoogle+Email
Practice News
Fewer gastroenterologists see drug company sales reps
More physicians, including gastroenterologists, are restricting pharmaceutical sales representative access, according to a report from ZS Associates. Data showed 47% of gastroenterologists were accessible to sales reps in 2014, compared with 63% in 2013. PhysiciansBriefing.com (7/28)
Share: LinkedInTwitterFacebookGoogle+Email
Business & Market Trends
Providers continue to use paper, pagers
A Frost & Sullivan report found many health care providers continue to rely on dated communication systems such as pagers and paper-based records, potentially compromising patient safety, operational efficiency and care delivery. The report recommends adoption of mobile communication methods along with deployment strategies designed to simplify the transition. Clinical Innovation + Technology online (7/24)
Share: LinkedInTwitterFacebookGoogle+Email
Patient's Perspective
Survey shows many uninsured are still unaware of ACA
An Urban Institute report said 59% of uninsured people who did not have insurance last year knew about the health insurance exchanges under the Affordable Care Act and 38% were aware of subsidies to make premiums more affordable. The survey found 60% of this group said they did not have insurance because of the cost, and 20% did not want insurance and preferred paying a fine for not having coverage. Kaiser Health News (7/29)
Share: LinkedInTwitterFacebookGoogle+Email
ACG News
GIQuIC -- quality of performance, dedication to continuous improvement
Participate in GIQuIC and demonstrate to your patients your commitment to quality in performance and dedication to continuous improvement. Participants in GIQuIC can run a myriad of customizable reports from the registry and benchmark their practice against established benchmarks and against others in the study. As one practice stated, "We've been able to use this data not only to start to devise ways to improve, but we've also started marketing to our patients -- showing them that we're doing better than the national benchmarks." Want to learn more? Visit www.giquic.org.
Share: LinkedInTwitterFacebookGoogle+Email
Infectious and Malignancy Risks with Immunomodulator and Biologic Therapies
Understand the risk of infection and malignancy in patients with IBD who are treated with commonly used immunomodulators and biologic therapies when you attend the ACG/VGS/ODSGNA Regional Postgraduate Course, September 6-7, at the Williamsburg Lodge in Williamsburg, Va. Other topics offered include Barrett’s Esophagus – Who to Treat and How?, Serrated Polyps and Polyposis, Interventions in Fecal Incontinence, Management of Pancreatic Cysts, Update on the Treatment of HCV, Update on Irritable Bowel Syndrome, and more. Saturday morning features a special nursing program, Hot Topics in Infection Prevention in the Endoscopy Unit. The VGS Keynote Lecture and Luncheon will feature Christina M. Surawciz, M.D., MACG, who will present Recognizing Burnout and Finding the Path to Recovery. Browse the course brochure and register.
Share: LinkedInTwitterFacebookGoogle+Email
SmartQuote
We must open the doors of opportunity. But we must also equip our people to walk through those doors."
-- Lyndon B. Johnson,
36th U.S. president
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about ACG® ->Homepage | Meetings | Resources | National Affairs
Digestive Health Resources
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Tara Rosenzweig
Advertising:  Hillary Batchelder
  P: 202.407.7803
 
 

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information